Detalhe da pesquisa
1.
Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study.
Oncologist
; 28(2): 187-e114, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477870
2.
Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA).
BMC Cancer
; 23(1): 308, 2023 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016303
3.
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
Mol Cancer
; 21(1): 57, 2022 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35189910
4.
Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial.
BMC Med
; 20(1): 107, 2022 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35382819
5.
Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study.
BMC Gastroenterol
; 22(1): 296, 2022 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35701768
6.
Tumor-derived LIF promotes chemoresistance via activating tumor-associated macrophages in gastric cancers.
Exp Cell Res
; 406(1): 112734, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265288
7.
Identification of key genes involved in tumor immune cell infiltration and cetuximab resistance in colorectal cancer.
Cancer Cell Int
; 21(1): 135, 2021 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33632198
8.
Reevaluation of lymphovascular invasion in gastric cancer using endothelial markers D2-40 and EVG: Enhanced detection, better predictor of lymph node metastasis and biological aggressiveness.
J Surg Oncol
; 123(8): 1736-1741, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772776
9.
A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.
J Cell Physiol
; 235(7-8): 5777-5786, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32048287
10.
Activated HIF1α of tumor cells promotes chemoresistance development via recruiting GDF15-producing tumor-associated macrophages in gastric cancer.
Cancer Immunol Immunother
; 69(10): 1973-1987, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32388677
11.
5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
J Cell Mol Med
; 23(5): 3530-3537, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30912288
12.
Oxaliplatin plus Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma in Combination with D2 Gastrectomy: NEO-CLASSIC Study.
Oncologist
; 24(10): 1311-e989, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31239311
13.
The role of oxaliplatin in the adjuvant setting of different Lauren's type of gastric adenocarcinoma after D2 gastrectomy: a real-world study.
Gastric Cancer
; 22(3): 587-597, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30426294
14.
Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.
Cell Physiol Biochem
; 45(5): 1731-1746, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29495008
15.
An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
Cell Physiol Biochem
; 50(2): 768-782, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30308491
16.
Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis.
BMC Cancer
; 18(1): 702, 2018 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954358
17.
Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.
Cell Physiol Biochem
; 39(3): 1239-46, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595400
18.
Efficacy of Pyrotinib With/Without Trastuzumab in Treatment-Refractory, HER2-Positive Metastatic Colorectal Cancer: Result From a Prospective Observational Study.
Clin Colorectal Cancer
; 23(1): 58-66, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177002
19.
Clinical significance of peripheral T-cell receptor repertoire profiling and individualized nomograms in patients with gastrointestinal cancer treated with anti-programmed death 1 antibody.
Transl Gastroenterol Hepatol
; 9: 5, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317746
20.
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies.
Clin Cancer Res
; 30(4): 719-728, 2024 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38032349